Jamieson Wellness Inc.
JWLLF
$19.88
-$0.7743-3.75%
| Weiss Ratings | JWLLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Good | |||
| Risk Index | Weak | |||
| Risk Grade | D+ | |||
| Reward Grade | B | |||
| Rating Factors | JWLLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Good | |||
| Growth Index | Excellent | |||
| Efficiency Index | Good | |||
| Solvency Index | Excellent | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | JWLLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.29 | |||
| Price History | JWLLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -11.92% | |||
| 30-Day Total Return | -15.38% | |||
| 60-Day Total Return | -24.05% | |||
| 90-Day Total Return | -22.53% | |||
| Year to Date Total Return | -23.98% | |||
| 1-Year Total Return | -12.30% | |||
| 2-Year Total Return | -7.64% | |||
| 3-Year Total Return | -17.60% | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -24.44% | |||
| 52-Week Low % Change | 5.42% | |||
| Price | JWLLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $26.51 | |||
| 52-Week Low Price | $19.00 | |||
| 52-Week Low Price (Date) | Mar 22, 2024 | |||
| 52-Week High Price (Date) | Nov 27, 2024 | |||
| Valuation | JWLLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 836.28M | |||
| Enterprise Value | 1.13B | |||
| Price/Earnings (TTM) | 23.10 | |||
| Earnings Per Share (TTM) | 0.87 | |||
| Earnings Per Share Growth | 4.41% | |||
| Price/Earnings To Growth | 5.25 | |||
| Price/Sales (TTM) | 1.62 | |||
| Price/Book (Q) | 2.39 | |||
| Enterprise Value/Revenue (TTM) | 2.14 | |||
| Price | $19.88 | |||
| Enterprise Value/EBITDA (TTM) | 14.14 | |||
| Enterprise Value/EBIT | 16.85 | |||
| Market Cap Category | Small Cap | |||
| Dividends and Shares | JWLLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 43.18M | |||
| Dividend Yield | 2.92% | |||
| Div. Per Share (Most Recent) | $0.15 | |||
| Dividend Per Share (TTM) | $0.59 | |||
| Payout Ratio (TTM) | 65.42% | |||
| Dividend Per Share (Most Recent) | $0.15 | |||
| Company Info | JWLLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 800 265 5088 | |||
| Address | 1 Adelaide Street East Toronto, ON M5C 2V9 | |||
| Website | www.jamiesonwellness.com | |||
| Country | Canada | |||
| Year Founded | 1922 | |||
| Profitability | JWLLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 12.73% | |||
| Profit Margin | 6.98% | |||
| Management Effectiveness | JWLLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 4.98% | |||
| Return on Equity | 9.86% | |||
| Income Statement | JWLLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 534.04M | |||
| Total Revenue (TTM) | 534.04M | |||
| Revenue Per Share | $12.37 | |||
| Gross Profit (TTM) | 200.40M | |||
| EBITDA (TTM) | 81.00M | |||
| EBIT (TTM) | 67.99M | |||
| Net Income (TTM) | 37.31M | |||
| Net Income Avl. to Common (TTM) | 37.31M | |||
| Total Revenue Growth (Q YOY) | 7.96% | |||
| Earnings Growth (Q YOY) | 46.27% | |||
| EPS Diluted (TTM) | 0.87 | |||
| EPS Diluted Growth (Q YOY) | 45.74% | |||
| Balance Sheet | JWLLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 31.13M | |||
| Cash Per Share (Q) | $0.72 | |||
| Total Current Assets (Q) | 303.68M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 381.13M | |||
| Current Ratio (Q) | 2.530 | |||
| Book Value Per Share (Q) | $8.37 | |||
| Total Assets (Q) | 840.12M | |||
| Total Current Liabilities (Q) | 120.01M | |||
| Total Debt (Q) | 296.70M | |||
| Total Liabilities (Q) | 458.99M | |||
| Total Common Equity (Q) | 351.10M | |||
| Cash Flow | JWLLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -7.37M | |||
| Cash from Financing (TTM) | -32.62M | |||
| Net Change in Cash (TTM) | 5.77M | |||
| Levered Free Cash Flow (TTM) | 32.01M | |||
| Cash from Operations (TTM) | 44.36M | |||
